Paychex, Inc. (PAYX) Stock Forecast
Data as of May 2, 2026Industrials · Current price $93.08 (+0.50%)
Price Target Range
Consensus Price Target Over Time
Analyst Rating Distribution
Last 3 Months
6-Month Trend
Latest Analyst Forecasts
Price targets issued by Wall Street analysts. Upside calculated against today's price.
| Date | Analyst | Firm | Price Target | Upside |
|---|---|---|---|---|
| Mar 27, 2026 | James Faucette | Morgan Stanley | $107.00 | +15.0% |
| Mar 13, 2026 | Daniel Jester | BMO Capital | $103.00 | +10.7% |
| Jan 26, 2026 | Ramsey El-Assal | Cantor Fitzgerald | $98.00 | +5.3% |
| Dec 17, 2025 | David Grossman | Stifel Nicolaus | $126.00 | +35.4% |
| Dec 5, 2025 | Ashish Sabadra | RBC Capital | $125.00 | +34.3% |
| Oct 6, 2025 | Charles Nabhan | Stephens | $135.00 | +45.0% |
| Sep 16, 2025 | Kevin McVeigh | UBS | $140.00 | +50.4% |
| Jun 24, 2025 | Peter Christiansen | Citigroup | $158.00 | +69.8% |
| Jun 24, 2025 | Ramsey El-Assal | Barclays | $155.00 | +66.5% |
| Jun 24, 2025 | Ashish Sabadra | RBC Capital | $165.00 | +77.3% |
| Oct 2, 2024 | Kevin McVeigh | UBS | $142.00 | +52.6% |
| Sep 22, 2024 | Ramsey El-Assal | Barclays | $132.00 | +41.8% |
| Jun 28, 2024 | John Eade | Argus Research | $135.00 | +45.0% |
| Jun 27, 2024 | James Faucette | Morgan Stanley | $122.00 | +31.1% |
| Jun 27, 2024 | Mark Marcon | Robert W. Baird | $124.00 | +33.2% |
| Jun 26, 2024 | David Togut | Evercore ISI | $130.00 | +39.7% |
| Apr 2, 2024 | David Togut | Evercore ISI | $116.00 | +24.6% |
| Apr 1, 2024 | David Grossman | Stifel Nicolaus | $130.00 | +39.7% |
| Sep 27, 2023 | James Faucette | Morgan Stanley | $125.00 | +34.3% |
| Sep 27, 2023 | Moshe Katri | Wedbush | $115.00 | +23.6% |
Top Analysts Covering PAYX
PAYX vs Sector & Market
| Metric | PAYX | Industrials Avg | Large Cap Avg |
|---|---|---|---|
| Analyst Rating | 3.25 | 2.41 | 2.41 |
| Analyst Count | 16 | 8 | 18 |
| Target Upside | +20.5% | +84.9% | +14.9% |
| P/E Ratio | 20.55 | 28.16 | 31.19 |
Revenue Estimates
| Period | Low | Avg | High | # |
|---|---|---|---|---|
| 2026-05-31 | $6.50B | $6.51B | $6.53B | 14 |
| 2026-08-28 | $1.60B | $1.62B | $1.63B | 7 |
| 2026-11-28 | $1.62B | $1.64B | $1.65B | 6 |
| 2027-02-28 | $1.89B | $1.90B | $1.93B | 6 |
| 2027-05-28 | $1.68B | $1.69B | $1.71B | 5 |
| 2027-05-31 | $6.82B | $6.86B | $6.96B | 14 |
| 2027-08-28 | $1.70B | $1.71B | $1.73B | 4 |
| 2027-11-28 | $1.71B | $1.73B | $1.75B | 3 |
| 2028-02-28 | $1.99B | $2.01B | $2.03B | 2 |
| 2028-05-28 | $1.77B | $1.79B | $1.81B | 2 |
| 2028-05-31 | $7.23B | $7.24B | $7.24B | 12 |
EPS Estimates
| Period | Low | Avg | High | # |
|---|---|---|---|---|
| 2026-05-31 | $5.48 | $5.50 | $5.51 | 12 |
| 2026-08-28 | $1.29 | $1.32 | $1.39 | 10 |
| 2026-11-28 | $1.34 | $1.36 | $1.38 | 7 |
| 2027-02-28 | $1.78 | $1.80 | $1.82 | 7 |
| 2027-05-28 | $1.42 | $1.43 | $1.45 | 7 |
| 2027-05-31 | $5.72 | $5.91 | $6.00 | 12 |
| 2027-08-28 | $1.38 | $1.40 | $1.42 | 7 |
| 2027-11-28 | $1.43 | $1.45 | $1.47 | 7 |
| 2028-02-28 | $1.89 | $1.91 | $1.93 | 8 |
| 2028-05-28 | $1.53 | $1.54 | $1.57 | 8 |
| 2028-05-31 | $5.97 | $6.30 | $6.48 | 8 |
Frequently Asked Questions
What is the analyst consensus for PAYX?
The consensus among 16 analysts covering Paychex, Inc. (PAYX) is Hold with an average price target of $117.00.
What is the highest price target for PAYX?
The highest price target for PAYX is $165.00, set by Ashish Sabadra at RBC Capital on 2025-06-24.
What is the lowest price target for PAYX?
The lowest price target for PAYX is $98.00, set by Ramsey El-Assal at Cantor Fitzgerald on 2026-01-26.
How many analysts cover PAYX?
16 analysts have issued ratings for Paychex, Inc. in the past 12 months.
Is PAYX a buy or sell right now?
Based on 16 analyst ratings, PAYX has a consensus rating of Hold (3.25/5) with a +20.5% upside to the consensus target of $117.00.
What are the earnings estimates for PAYX?
Analysts estimate PAYX will report EPS of $5.50 for the period ending 2026-05-31, with revenue estimated at $6.51B.
Related Stock Forecasts
Data updated daily. Analyst price targets sourced from public filings and broker reports. Not investment advice.